Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/2005
06/15/2005EP1541553A1 Novel indoline compound and medicinal use thereof
06/15/2005EP1541175A2 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
06/15/2005EP1541170A1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
06/15/2005EP1541149A1 Phosphodiesterase inhibitor
06/15/2005EP1541145A1 The use of benzisoselenazolone compounds against ischemic myocardial damage
06/15/2005EP1541139A1 Drug composition containing nf-kappa b inhibitor
06/15/2005EP1539933A2 Methods of organ regeneration
06/15/2005EP1539769A1 Bicyclic heteroaromatic compounds as kinase inhibitors
06/15/2005EP1539766A1 Calcitonin gene related peptide receptor antagonists
06/15/2005EP1539763A1 Azaindole kinase inhibitors
06/15/2005EP1539762A2 Bicyclic pyrimidinones as coagulation cascade inhibitors
06/15/2005EP1539760A2 Azapurine derivatives
06/15/2005EP1539748A1 2-phenylpyridin-4-yl derivatives as alk5 inhibitors
06/15/2005EP1539746A1 N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes
06/15/2005EP1539742A1 Indole derivatives useful as histamine h3 antagonists
06/15/2005EP1539741A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics
06/15/2005EP1539739A1 Piperidinyl compounds that selectively bind integrins
06/15/2005EP1539732A1 Novel compounds
06/15/2005EP1539727A2 Compounds, compositions, and methods
06/15/2005EP1539721A1 Dibenzoxazepine
06/15/2005EP1539713A1 Pyrimidine derivatives as modulators of chemokine receptor activity
06/15/2005EP1539710A1 Heterocyclic derivatives
06/15/2005EP1539709A1 Azaisoquinoline derivatives as matrix metalloproteinase inhibitors
06/15/2005EP1539707A1 Method and compounds for promoting healing and reducing inflammation
06/15/2005EP1539701A1 Caspase inhibitors and uses thereof
06/15/2005EP1539696A2 Process for preparing quinolin antibiotic intermediates
06/15/2005EP1539695A1 N-4-piperidinyl compounds as ccr5 modulators
06/15/2005EP1539693A1 Cannabinoid receptor agonists
06/15/2005EP1539689A2 Antisense modulation of endothelial lipase expression
06/15/2005EP1539686A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
06/15/2005EP1539685A1 Mcp-1 receptor antagonists and method of use thereof
06/15/2005EP1539683A2 Phenol derivatives and their use as rotamase inhibitors
06/15/2005EP1539679A2 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
06/15/2005EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands
06/15/2005EP1539674A1 Amino-propanol derivatives
06/15/2005EP1539662A1 Cannabinoid receptor ligands
06/15/2005EP1539284A2 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
06/15/2005EP1539270A1 Controllable drug releasing gradient coatings for medical devices
06/15/2005EP1539216A2 Labelled somatostatin analogs backbone cyclized through metal complexation
06/15/2005EP1539213A2 Cardioprotective therapies based on enzymatic elimination of lipid peroxides by allene oxide synthase
06/15/2005EP1539208A2 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds
06/15/2005EP1539180A2 Compounds, compositions, and methods
06/15/2005EP1539177A2 Compositions and methods for treating heart disease
06/15/2005EP1539171A2 Use of chymase inhibitors for the prevention and/or treatment of arterio-venous graft failure
06/15/2005EP1539166A1 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
06/15/2005EP1539140A1 Carvedilol hydobromide
06/15/2005EP1539137A1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
06/15/2005EP1539131A2 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies
06/15/2005EP1539129A1 Dosage forms and related therapies
06/15/2005EP1539120A1 Combination of an ibat inhibitor and a metal salt for the treatment of diarrhoea
06/15/2005EP1539041A1 Devices delivering therapeutic agents and methods regarding the same
06/15/2005EP1538913A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
06/15/2005EP1439831B1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
06/15/2005EP1427842A4 Mid 9002, a human sulfatase family member and uses therefor
06/15/2005EP1408977B1 A combination therapy for the treatment of heart failure
06/15/2005EP1373240B1 Retinoid x receptor modulators
06/15/2005EP1345609B1 Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists
06/15/2005EP1341764B1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
06/15/2005EP1325007B1 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction
06/15/2005EP1289916A4 Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls
06/15/2005EP1257277B1 New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent
06/15/2005EP1248785B1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
06/15/2005EP1198255A4 Identification of compounds that modify transcriptional responses to hypoxia
06/15/2005EP1174134B1 Melatonin for treating paralysis caused by cerebral infarction
06/15/2005EP1150973B1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
06/15/2005EP1114031B1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
06/15/2005EP1104412B1 Tace inhibitors
06/15/2005EP1001979B1 Cyclic azapeptides with angiogenic effect
06/15/2005EP0998556B1 Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1)
06/15/2005EP0975602B1 Imidazole and imidazoline derivatives and uses thereof
06/15/2005EP0956031B1 Inhibition of 26 s and 20 s proteasome by indanones
06/15/2005EP0906108B1 Endothelin antagonists for treating heart failure
06/15/2005CN1628116A Inhibitors of alpha l beta 2 integrin mediated cell adhesion
06/15/2005CN1628111A 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
06/15/2005CN1628107A Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
06/15/2005CN1628106A Salts of valsartan
06/15/2005CN1628103A Pyrimidine derivitive
06/15/2005CN1628101A 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
06/15/2005CN1628099A Water soluble phenylglycine derivatives
06/15/2005CN1627970A Safety shield system for prefilled syringe
06/15/2005CN1627946A Carboximide derivatives as useful uro-selective alpha-1A adrenoceptor blockers
06/15/2005CN1627945A Quinoline derivatives as NPY antagonists
06/15/2005CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
06/15/2005CN1626516A Novel intermediate for prepn. of pyrazolopyrimidinones
06/15/2005CN1626227A Freeze-dried powder and injection preparation of red sage root and safflower, and preparation method
06/15/2005CN1626216A Extractive from combined vegetable drug for treating heart disease of coronary sclerosis, and method of extraction
06/15/2005CN1626208A Preparation of fleabane and preparation method
06/15/2005CN1626206A Compound preparation of fleabane for treating cardiovascular and cerebrovascular diseases, and preparation method
06/15/2005CN1626200A Injection preparation for generating channels and vessels, and preparation method
06/15/2005CN1626199A Powder injection preparation for generating channels and vessels, and preparation method
06/15/2005CN1626197A Method for preparing external and internal remedies for treating diseases of AIDS, ulcer of oral cavity, burn and scald, and usage
06/15/2005CN1626195A Preparation of Chinese traditional medicine for treating coronary heart disease and angina as well as preparation method
06/15/2005CN1626193A Plaster for treating the bone disease
06/15/2005CN1626177A Powder injection of astragalus root and preparation method
06/15/2005CN1626173A Sugarless type oral liquid of rehmannia root including six elements
06/15/2005CN1626159A Method for preparing pills of quenching dizziness
06/15/2005CN1626148A Medication for treating cardiovascular and cerebrovascular diseases
06/15/2005CN1626147A Medication for treating coronary heart disease and angina
06/15/2005CN1626146A Icy seven drop pills and preparation method
06/15/2005CN1626142A Medication for treating coronary heart disease and angina
1 ... 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 ... 1595